Buscar resultados de ensayos clínicos
Nerve Sheath Neoplasms - 25 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas Condición: Neurofibroma Fecha: 2008-07-14 Intervenciones: Drug: LS11 LS11 will be given as a one-time IV infusion over 3-5 minutes. |
Terminated |
Nombre del estudio: First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas Condición: Cutaneous Neurofibromas Fecha: 2009-06-15 Intervenciones: Procedure: Erbium-YAG laser vaporization spot size 2-5 mm diameter, applying about 1,2 -2 J at a frequen |
Active, not recruiting |
Nombre del estudio: Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas Condición:
Fecha: 2010-06-08 Intervenciones: Drug: Gleevec Gleevec will be dosed orally with a starting dose of 100 mg twice daily for patients with |
Active, not recruiting |
Nombre del estudio: Study of PEG-Intron for Plexiform Neurofibromas Condición: Plexiform Neurofibroma Fecha: 2006-11-02 Intervenciones: Drug: PEG-Intron |
Terminated |
Nombre del estudio: Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors Condición: Malignant Peripheral Nerve Sheath Tumors Fecha: 2007-01-25 Intervenciones: Drug: imatinib mesylate |
Recruiting |
Nombre del estudio: Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors Condición: Malignant Peripheral Nerve Sheath Tumors Fecha: 2017-04-13 |
Recruiting |
Nombre del estudio: Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas Condición: Plexiform Neurofibromas Fecha: 2014-06-25 Intervenciones: Drug: Imatinib Mesylate oral administration Other Na |
Terminated |
Nombre del estudio: Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1) Condición: Plexiform Neurofibroma Associated With Neurofibromatosis Type 1 Fecha: 2011-05-27 Intervenciones: Drug: Everolimus (RAD001) oral daily dosing of tablet starting with 2.5 mg |
Recruiting |
Nombre del estudio: A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery Condición: Malignant Peripheral Nerve Sheath Tumour (MPNST) Fecha: 2016-02-04 Intervenciones: Drug: Pembrolizumab Other Name: Keytruda |
Completed |
Nombre del estudio: Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1 Condición:
Fecha: 2008-03-27 Intervenciones: Drug: Ranibizumab Given as an injection into three cutaneous neurofibromas on day 1 of the study treatme |